A retrospective, cohort study of association of small bowel and colonic mucosal eosinophil density in IBD patients before the start of vedolizumab and associate the density with the clinical response to vedolizumab therapy during the initial 6 months of treatment
Latest Information Update: 07 Oct 2021
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 07 Oct 2021 New trial record